The Medical Technology Enterprise Consortium (MTEC) is a internationally-dispersed consortium with members from industry, academia and the nonprofit sector that aims to be the partner of choice for private industry, academic institutions, government agencies, and other research organizations seeking to accelerate the development of medical solutions that prevent and treat injuries and restore America’s military and veterans to full health.
It is a 501(c)(3) biomedical technology consortium collaborating with multiple government agencies under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command (USAMRDC). MTEC represents a first-of-its-kind construct that combines the “traditional” government-funded prototype project work with the ability to raise and execute private sector funding.
In partnership with the Department of Defense and private support, MTEC is working to prevent injuries and accelerate the development of revolutionary medical solutions. Ultimately, all citizens will benefit from these technologies and healthcare solutions.
advanced medical technologies, Artificial Intelligence (AI), Biologics, Biotech, Blood and Blood Products, bone scaffolding, Broad Spectrum Antivirals, Casualty Management, clinical and rehabilitative medicine, Combat Casualty Care, Control of Wound Progression & Infection Prevention, Diagnostic and Detection Devices, Drugs, health informatics systems, Hearing Loss from Blast Exposure, Human Machine Integration, Infectious Diseases, Maximizing Human Potential, Medical logistics, Medical Readiness, Medical Simulation and Information Sciences, medical training and health information sciences, military infectious diseases, Military Operational Medicine, Musculoskeletal Injury, Non-Compressible Hemorrhage, Post-traumatic stress disorder (PTSD), Prolonged Field Care, Psychological Health and Resilience to Stressors, Rapid Treatment and Return to Duty for Burn Injury, simulation based technologies, stem cell-enabled treatment, Suicide prevention, Synthetic Biology, Telehealth technologies, tissue regeneration, Traumatic Brain Injury (TBI), Vaccine platforms for Emerging Infectious Diseases, Vaccines, Warfighter Performance